Inside Health Security: How Professionals Prepare for the Next Crisis

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Ask ten people what health security means and you’ll get maybe six answers.” It has outbreak detection, lab safety, stockpiling, border policy, and then the paperwork nobody likes. The one thing that ties it all together is a fear that something will move faster than the system designed to catch it. There is a history […]

The post Inside Health Security: How Professionals Prepare for the Next Crisis appeared first on Medical News Bulletin.

Ten Ways to Achieve a Natural Appearance After Plastic Surgery

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

It is never an easy thing to get used to the new self after plastic surgery. There is usually some time required to be able to fully embrace the new self. Swellings and bruises tend to make the area appear undesirable during the early stages of recovery. Many people are usually worried about not looking […]

The post Ten Ways to Achieve a Natural Appearance After Plastic Surgery appeared first on Medical News Bulletin.

Dopamine: A Forward-Looking Reward

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

A new study from Harvard University published in Nature Neuroscience offers a fresh look at how our brains learn from reward. The study shows dopamine, often called the brain’s “reward chemical,” plays a much more complex role than previously thought. Rather than simply reinforcing past rewards, dopamine helps the brain predict future outcomes in a […]

The post Dopamine: A Forward-Looking Reward appeared first on Medical News Bulletin.

Diet, cardiovascular health, social factors impact glaucoma risk

NEW ORLEANS — Although polygenic risk scores can be a useful tool in glaucoma, ophthalmologists should also be aware of patient lifestyle and environmental factors, according to a presenter.
“We all routinely encounter patients in our clinics who have a relative who has lost their vision from glaucoma. They always ask us, ‘Is there anything I can do to lower my risk?’” Inas F. Aboobakar, MD, said during a presentation at Glaucoma Subspecialty Day at the American Academy of Ophthalmology meeting. “We know in recent years from many studies that glaucoma is a

Macular carotenoids show no retinal effect in 3 months of use

ANAHEIM, Calif. — Three months of carotenoid supplementation had no significant impact on markers of retinal health, according to data presented at Academy 2026.
“[The macula] contains high concentrations of three carotenoids — lutein, zeaxanthin and meso-zeaxanthin — that are thought to help protect the retina by filtering short-wavelength light and providing antioxidant protection,” Aditi Deshpande, MS, PhD, of the Pacific University College of Optometry, told Healio. “Because of their potential role in retinal health, macular carotenoids have become an important area of nutritional and

FDA approves Hovilpri for herpes simplex virus lesions

The FDA has approved pritelivir to treat mucocutaneous lesions caused by herpes simplex virus in immunocompromised adult patients who have not responded to previous therapies.
The approval of pritelivir (Hovilpri, Asahi Kasei), an antiviral drug that the FDA granted priority review in April, was based on data from the randomized, controlled, open-label, phase 3 PRIOH-1 study. As Healio previously reported, the phase 3 trial found that pritelivir demonstrated “superior efficacy” in healing lesions in immunocompromised patients.
The study, presented at the Conference on Retroviruses and

Mix-and-match approach to RLE may improve patient satisfaction

NEW ORLEANS — Implanting different IOLs in refractive lens exchange may improve patient satisfaction, according to a speaker at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology meeting.
R. Luke Rebenitsch, MD, said when it comes to refractive lens exchange (RLE), it is nearly impossible to promise spectacle independence; instead, the goal should be to make the patient happy with their vision.
“RLE surgery is not cataract surgery,” he said in his presentation. “The expectations are extraordinarily high. You have to customize to visual demands. Everyone’s coming in

Patient-centered menopause care in the digital age

Providing perimenopausal and menopausal patient care can be challenging, even for seasoned clinicians.
In a 2024 JAMA Health Forum study, researchers noted that the prevalence of menopausal hormone therapy (MHT) use declined from 26.9% of postmenopausal women in 1999 to 4.7% in 2020, creating an environment in which many healthcare professionals today lack the training and experience to prescribe MHT as a treatment option for menopausal symptoms.
In early 2026, extensive lay media coverage of the FDA’s labeling changes for menopausal hormone therapy products brought this topic to the forefront

FDA approves Tecentriq combination for dMMR colon cancer

The FDA has approved atezolizumab plus chemotherapy as an adjuvant treatment for patients aged 2 years and older with stage III mismatch repair deficient colon cancer.
Atezolizumab (Tecentriq, Genentech) in combination with a fluoropyrimidine and oxaliplatin is now the first adjuvant immunotherapy regimen approved for stage III mismatch repair deficient (dMMR) colon cancer, with atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech) approved for patients aged 12 years and older who weigh at least 40 kg.
“Until now, the adjuvant standard of care for stage III colon cancer has not